COMMUNIQUÉS West-GlobeNewswire

Shire plc : Notice of Results
18/04/2018
Shire to announce first quarter 2018 results Dublin, Ireland - April 18, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce first quarter 2018 earnings on Thursday April 26, 2018. Results press release will be [...]
Active Biotech: Notice of Annual General Meeting of Shareholders
18/04/2018
The Board of Directors of Active Biotech AB (publ) has issued a notice to the Annual General Meeting, which is to take place on Thursday, May 17, 2018, at 5 pm at the company's offices, Scheelevägen 22 in Lund, Sweden. [...]
Pathway Health Selected as Training and Implementation Partner for the Managed Care MASTER Application
18/04/2018
LAKE ELMO, Minn., April 18, 2018 (GLOBE NEWSWIRE) -- Pathway Health has been selected by Prime Care Technologies and its affiliate Managed Care Group LLC as their implementation, training and ongoing support services [...]
Endonovo Therapeutics Inc. to Move Forward with a Clinical Research Study Conducted by the Regents of the University of New Mexico
18/04/2018
Los Angeles, CA, April 18, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
18/04/2018
FIT Biotech Oy Company release April 18, 2018 at 4:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
BriaCell Provides Highlights of Scientific and Clinical Findings at AACR
18/04/2018
- Early data points to safety and early efficacy of Bria-IMT™ in Advanced Stage IV Breast cancer - BERKELEY, Calif. and VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" [...]
VitalHub Reports 2017 Year End and Fourth Quarter Financial Results
18/04/2018
TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) has released its audited financial results for the full year and fourth quarter ended December 31, 2017. When asked to [...]
Scythian Announces ABP S.A.’s First Purchase Order with Aphria Inc.
18/04/2018
– Order to Supply World Renowned Pediatric Hospital for Research and Education – TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) ( [...]
Genocea Presents Data at AACR Annual Meeting Further Highlighting Advantages of ATLAS Platform in Identification of Neoantigens over in silico Methods
18/04/2018
- ATLAS data demonstrate in silico methods miss most empirically confirmed neoantigens - - ATLAS able to identify inhibitory neoantigens - - Mouse ATLAS melanoma model developed to study mechanism of inhibitory antigens [...]
OncoMed Presents Multiple Preclinical Abstracts Related to Immuno-Oncology Programs at the 2018 American Association for Cancer Research Annual Meeting
18/04/2018
REDWOOD CITY, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ: OMED ), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]
Ogilvy CommonHealth Worldwide’s Goss and Sherman tapped to present at 2018 DTC National Conference
18/04/2018
PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced Catherine Goss, SVP, managing [...]
New Data Shows Biodesix Blood Test Reliably Detects Additional Mutations in Patients with NSCLC
18/04/2018
Highly multiplexed ddPCR-based assay currently in use by biopharma partners BOULDER, Colo., April 18, 2018 (GLOBE NEWSWIRE) -- Biodesix ® , Inc. is presenting new data today demonstrating the ability of the company’s [...]
AXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti-Fungal Activities
18/04/2018
NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (AXIM ® Biotech ), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the European Patent Office (EPO) has [...]
Checkpoint Therapeutics Reports Preclinical Data on BET Inhibitor CK-103 at the American Association for Cancer Research Annual Meeting
18/04/2018
Data support the commencement of a first-in-human Phase 1 trial NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology [...]
Mydx Announces 2017 Fiscal Year Results
18/04/2018
Gross Profit Margin Surged to 73% with Gross Profits Remaining Relatively Flat at ~$306K as MyDx Continues to Execute on its Long-Term Strategy SAN DIEGO, CA , April 18, 2018 (GLOBE NEWSWIRE) -- MyDx, Inc. ( OTC: MYDX [...]
TG Therapeutics, Inc. Announces Preclinical Data Presentation on the Company’s BET Inhibitor, TG-1601, at the 2018 American Association for Cancer Research (AACR) Annual Meeting
18/04/2018
NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today announced preclinical data for TG-1601, the Company’s novel BET inhibitor at the American Association for Cancer Research (AACR) [...]
BioPorto appoints Ole Larsen as CFO
18/04/2018
April 18, 2018 Announcement no. 9 Ole Larsen, Executive Vice President & CFO of Bavarian Nordic, will as of June 1, 2018, join BioPorto as the new Chief Financial Officer. In 2008, Ole Larsen joined Bavarian Nordic [...]
CV Sciences, Inc. Announces Silver Level Sponsorship of the 15th Annual Nutrition and Health Conference in Boston, Massachusetts - April 29-May 2, 2018
18/04/2018
Company Continues its Expansion into the Healthcare Professional Market through One-on-One Education, Exclusive Product Offerings and Enhanced Practitioner Support. LAS VEGAS, April 18, 2018 (GLOBE NEWSWIRE) -- CV [...]
Marrone Bio Innovations, Inc. Announces Pricing of Its Common Stock Offering
18/04/2018
DAVIS, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (or "the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and [...]

Pages